Transposagen Announces Partnering Model for its Exclusive Patents Covering Rat Models of Oncology, Autoimmune and Inflammatory Diseases and Issuance of OncoRat™ Registered Trademark

Lexington, KY, April 16, 2015 (GLOBE NEWSWIRE)

Transposagen, a world leader in genome engineering technologies and services, announced the registration of its trademark OncoRat™ by the USPTO, for use with rat models for oncology in issued patent No. 8,722,964. OncoRat™ covers all genetically engineered rat models with oncology phenotypes, regardless of the method used to create the rat model (e.g. site-specific nucleases, homologous recombination, transposon insertion, etc.).

Read More